Table 3 Gene expression profile of MCM7 in cancer tissues analyzed by cDNA microarray*
| Â | Â | Ratio (Tumor/Normal) | ||
|---|---|---|---|---|
Tissue type | Case (n) | Count > 2 (T/N) | Count > 3 (T/N) | Count > 5 (T/N) |
NSCLC | 37 | 9 (24.3%) | 4 (10.8%) | 0 (0%) |
SCLC | 15 | 12 (80.0%) | 9 (60.0%) | 2 (13.3%) |
Esophageal cancer | 62 | 37 (59.7%) | 28 (45.2%) | 12 (19.4%) |
Colorectal cancer | 42 | 17 (40.5%) | 9 (21.4%) | 0 (0%) |
Liver cancer | 20 | 8 (40.0%) | 5 (25.0%) | 1 (5.0%) |
Pancreatic cancer | 18 | 8 (44.4%) | 3 (16.7%) | 1 (5.6%) |
Bladder cancer | 34 | 33 (97.1%) | 23 (67.6%) | 11 (34.4%) |
Testicular cancer | 13 | 10 (76.9%) | 7 (53.8%) | 4 (30.8%) |
AML | 56 | 18 (32.1%) | 6 (10.7%) | 1 (1.8%) |
Osteosarcoma | 25 | 13 (52.0%) | 6 (24.0%) | 2 (8.0%) |
Soft tissue tumor | 63 | 51 (81.0%) | 35 (55.6%) | 16 (25.4%) |